Cargando…

Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms

Concerns regarding increased antibiotic resistance arising from the emergent properties of biofilms have spurred interest in the discovery of novel antibiotic agents and techniques to directly estimate metabolic activity in biofilms. Although a number of methods have been developed to quantify biofi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miran, Waheed, Naradasu, Divya, Okamoto, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859304/
https://www.ncbi.nlm.nih.gov/pubmed/33554070
http://dx.doi.org/10.1016/j.isci.2021.102068
_version_ 1783646701648609280
author Miran, Waheed
Naradasu, Divya
Okamoto, Akihiro
author_facet Miran, Waheed
Naradasu, Divya
Okamoto, Akihiro
author_sort Miran, Waheed
collection PubMed
description Concerns regarding increased antibiotic resistance arising from the emergent properties of biofilms have spurred interest in the discovery of novel antibiotic agents and techniques to directly estimate metabolic activity in biofilms. Although a number of methods have been developed to quantify biofilm formation, real-time quantitative assessment of metabolic activity in label-free biofilms remains a challenge. Production of electrical current via extracellular electron transport (EET) has recently been found in pathogens and appears to correlate with their metabolic activity. Accordingly, monitoring the production of electrical currents as an indicator of cellular metabolic activity in biofilms represents a new direction for research aiming to assess and screen the effects of antimicrobials on biofilm activity. In this article, we reviewed EET-capable pathogens and the methods to monitor biofilm activity to discuss advantages of using the capability of pathogens to produce electrical currents and effective combination of these methods. Moreover, we discussed EET mechanisms by pathogenic and environmental bacteria and open questions for the physiological roles of EET in pathogen's biofilm. The present limitations and possible future directions of in situ biofilm metabolic activity assessment for large-scale screening of antimicrobials are also discussed.
format Online
Article
Text
id pubmed-7859304
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78593042021-02-05 Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms Miran, Waheed Naradasu, Divya Okamoto, Akihiro iScience Review Concerns regarding increased antibiotic resistance arising from the emergent properties of biofilms have spurred interest in the discovery of novel antibiotic agents and techniques to directly estimate metabolic activity in biofilms. Although a number of methods have been developed to quantify biofilm formation, real-time quantitative assessment of metabolic activity in label-free biofilms remains a challenge. Production of electrical current via extracellular electron transport (EET) has recently been found in pathogens and appears to correlate with their metabolic activity. Accordingly, monitoring the production of electrical currents as an indicator of cellular metabolic activity in biofilms represents a new direction for research aiming to assess and screen the effects of antimicrobials on biofilm activity. In this article, we reviewed EET-capable pathogens and the methods to monitor biofilm activity to discuss advantages of using the capability of pathogens to produce electrical currents and effective combination of these methods. Moreover, we discussed EET mechanisms by pathogenic and environmental bacteria and open questions for the physiological roles of EET in pathogen's biofilm. The present limitations and possible future directions of in situ biofilm metabolic activity assessment for large-scale screening of antimicrobials are also discussed. Elsevier 2021-01-19 /pmc/articles/PMC7859304/ /pubmed/33554070 http://dx.doi.org/10.1016/j.isci.2021.102068 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Miran, Waheed
Naradasu, Divya
Okamoto, Akihiro
Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms
title Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms
title_full Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms
title_fullStr Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms
title_full_unstemmed Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms
title_short Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms
title_sort pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859304/
https://www.ncbi.nlm.nih.gov/pubmed/33554070
http://dx.doi.org/10.1016/j.isci.2021.102068
work_keys_str_mv AT miranwaheed pathogenselectrogenicityasatoolforinsitumetabolicactivitymonitoringanddrugassessmentinbiofilms
AT naradasudivya pathogenselectrogenicityasatoolforinsitumetabolicactivitymonitoringanddrugassessmentinbiofilms
AT okamotoakihiro pathogenselectrogenicityasatoolforinsitumetabolicactivitymonitoringanddrugassessmentinbiofilms